← Back to patent-cliff list
CAS 142356-40-9
2-bromo-5,6-dichloro-1H-benzo[d]imidazole
Codes: MARI-001
Application context (from source-drug indications)
巨细胞病毒感染MaribavirHaematological malignancyMaribavirHIV infectionMaribavir
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Maribavir | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 2-BROMO-5,6-DICHLOROBENZIMIDAZOLE Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.